Private Institute Briefs

At a time when the supply of live animals for research use has become unreliable, expensive, and controversial, a Philadelphia organization is providing experimenters with a convenient alternative: human tissue. The National Disease Research Interchange, founded by Lee Ducat and funded in part by NIH grants, links scientists into a nationwide network of organ banks and hospitals whose excess surgical, transplant, and autopsy material would otherwise go to waste. In business for the past decade,

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

At least 80 diseases are now under investigation by the Interchange's patrons. Ophthalmology researcher Peter Gouras of Columbia University says that if researchers "want human tissues, this is an excellent organization to work with. They aren't expensive, and they are very helpful." Based in Philadelphia, NDRI perfunctorily reviews applications to check that the research is appropriate, says Ducat. Only one applicant has ever been turned away, and that was because the request was technically impossible to meet. NDRI will work with scientists to develop protocols for preserving and handling the desired tissue. For application information, call (800) 222-6374.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies